Site-specific HNK-1 epitope on alternatively spliced fibronectin type-III repeats in tenascin-C promotes neurite outgrowth of hippocampal neurons through contactin-1 | PLOS ONE
Gems of Software Engineering Wisdom
Anthony J James posted on LinkedIn
Michal Šperk - Project Specialist - ROPID | LinkedIn
Biomedicines | Free Full-Text | HAT- and HDAC-Targeted Protein Acetylation in the Occurrence and Treatment of Epilepsy
Corticotropin-Releasing Factor Receptor-1 Neurons in the Lateral Amygdala Display Selective Sensitivity to Acute and Chronic Ethanol Exposure | eNeuro
The minds behind the TenX payment platform. Part 1 | by dedicatedguy | Medium
Michal Šperk - Project Specialist - ROPID | LinkedIn
Materials | May-2 2020 - Browse Articles
Michael Sperk - Co-founder and Engineering Lead @ TenX - Crunchbase Person Profile
Michal Šperk - Project Specialist - ROPID | LinkedIn
Brain Sciences | Free Full-Text | Emerging Neurological and Psychobiological Aspects of COVID-19 Infection
The BCL-2 Inhibitor Venetoclax Augments Immune Effector Function Mediated by Fas Ligand, TRAIL, and Perforin/Granzyme B, Resulting in Reduced Plasma Viremia and Decreased HIV Reservoir Size during Acute HIV Infection in a
2022 International Society of Intraoperative Radiation Therapy (ISIORT)
Arlene Sperk - Cuyahoga Community College - Berea, Ohio, United States | LinkedIn
![Molecules | Free Full-Text | Effective Preparation of [18F]Flumazenil Using Copper-Mediated Late-Stage Radiofluorination of a Stannyl Precursor](https://www.mdpi.com/molecules/molecules-27-05931/article_deploy/html/images/molecules-27-05931-g001-550.jpg "Molecules | Free Full-Text | Effective Preparation of [18F]Flumazenil Using Copper-Mediated Late-Stage Radiofluorination of a Stannyl Precursor")
Molecules | Free Full-Text | Effective Preparation of [18F]Flumazenil Using Copper-Mediated Late-Stage Radiofluorination of a Stannyl Precursor
Michael A. Sperk – Inhaber – MASPERK CONSULTING | LinkedIn
TARGIT-A randomised clinical phase-III trial of single-dose IORT (TARGIT-IORT) for early-stage breast cancer patients
Michael A. Sperk – Inhaber – MASPERK CONSULTING | LinkedIn
Michael Sperk - Co-founder and Engineering Lead @ TenX - Crunchbase Person Profile
Saif Al Suwaidi on LinkedIn: Anybody can become angry-that is easy; but to be angry with the right… | 12 comments
Expansion sequencing: Spatially precise in situ transcriptomics in intact biological systems | Science
Nejdůležitější je dostat k novinářům prachy, říká šéfredaktor Info.cz Michal Půr | e15.cz
TARGIT-A randomised clinical phase-III trial of single-dose IORT (TARGIT-IORT) for early-stage breast cancer patients
3 "Michael A. Sperk" profiles | LinkedIn
